Multisite Studies: Communication Among IRBs, Investigators, and Sponsors - PowerPoint PPT Presentation

About This Presentation
Title:

Multisite Studies: Communication Among IRBs, Investigators, and Sponsors

Description:

... medical history, physical examination, assessment of adverse events, blood test, ... (b) the clinical trial-related medical services are typically provided by the ... – PowerPoint PPT presentation

Number of Views:34
Avg rating:3.0/5.0
Slides: 33
Provided by: marisue
Category:

less

Transcript and Presenter's Notes

Title: Multisite Studies: Communication Among IRBs, Investigators, and Sponsors


1
Multisite Studies Communication Among IRBs,
Investigators, and Sponsors
  • Marisue Cody, PhD
  • Deputy Director, PRIDE

2
Objectives
  • Understand the concept of engagement
  • Be able to determine, when the institution is the
    lead institution, the added responsibilities of
    the IRB

3
Regulations
  • 38 CFR 16.114 Cooperative research.
  • Cooperative research projects are those projects
    covered by this policy which involve more than
    one institution. In the conduct of cooperative
    research projects, each institution is
    responsible for safeguarding the rights and
    welfare of human subjects and for complying with
    this policy. With the approval of the dept or
    agency head, an institution participating in a
    cooperative project may enter into a joint review
    arrangement, rely upon the review of another
    qualified IRB, or make similar arrangements for
    avoiding duplication in effort.

4
VA requirements
  • VHA Handbook 1200.5
  • Paragraph 5.a.(3)-each VA facility must have a
    designated IRB of record
  • Allows for use of university affiliate (medical
    or dental school), or another VA Medical Center
  • VHA Handbook 1058.03
  • Paragraph 5.a. FWAs and MOUs

5
Questions
  • Can you enter into an interagency agreement so
    that you will not have to duplicate the review of
    your academic affiliate?
  • Can you rely on the review of CDC if you are
    participating in a CDC sponsored study through an
    interagency agreement?

6
AAHRPP and multisite studies
  • II.8.A The research review unit has and follows
    policies and procedures for communication among
    IRBs, when appropriate, for research conducted at
    multiple sites (e.g., multi-site clinical trials,
    epidemiology studies, or educational surveys).

7
Required written materials
  • When the investigator plans to conduct research
    at external sites that are engaged in the
    research, policies and procedures have the IRB
    informed of
  • Contact information for the site.
  • Whether the site has granted permission for the
    research to be conducted.
  • Whether the site has an IRB and if so, whether it
    has approved the research or will rely upon the
    organizations IRB

8
Engagement in Human Research
  • A VA facility is engaged in human subject
    research (and needs an Assurance) whenever its
    employees or agents
  • Intervene or interact with living individuals for
    research purposes, or
  • Obtain, release, or access individually-identifiab
    le private information (or individually-identifiab
    le specimens) for research purposes
  • VHA Handbook 1200.53.b.
  • (See also 38 CFR 16.102(f))

9
Examples of Engagement OHRP Guidance October
2008
  • A.(1) Institutions that receive an award through
    a grant, contract, or cooperative agreement
    directly from HHS for the non-exempt human
    subjects research (i.e. awardee institutions),
    even where all activities involving human
    subjects are carried out by employees or agents
    of another institution.

Question When is your nonprofit considered
engaged?
10
Examples of Engagement OHRP Guidance October
2008
  • A.(2) Institutions whose employees or agents
    intervene for research purposes with any human
    subjects of the research by performing invasive
    or noninvasive procedures. Examples of invasive
    or noninvasive procedures include drawing blood
    collecting buccal mucosa cells using a cotton
    swab administering individual or group
    counseling or psychotherapy administering drugs
    or other treatments surgically implanting
    medical devices utilizing physical sensors and
    utilizing other measurement procedures. See
    scenarios B.(1), B.(2), and B.(3) below for
    limited exceptions.

Question Who is an agent?
11
Examples of Engagement OHRP Guidance October 2008
  • A.(3) Institutions whose employees or agents
    intervene for research purposes with any human
    subject of the research by manipulating the
    environment. Examples of manipulating the
    environment include controlling environmental
    light, sound, or temperature presenting sensory
    stimuli and orchestrating environmental events
    or social interactions. See scenarios B.(1)
    and B.(3) below for limited exceptions.

12
Examples of Engagement OHRP Guidance October 2008
  • A.(4) Institutions whose employees or agents
    interact for research purposes with any human
    subject of the research. Examples of
    interacting include engaging in protocol dictated
    communication or interpersonal contact asking
    someone to provide a specimen by voiding or
    spitting into a specimen container and
    conducting research interviews or administering
    questionnaires. See scenarios B.(1), B.(2),
    B.(3), and B.(4) below for limited exceptions.

13
Examples of Engagement OHRP Guidance October 2008
  • A.(5) Institutions whose employees or agents
    obtain the informed consent of human subjects for
    the research.

14
Examples of Engagement OHRP Guidance October 2008
  • A.(6) Institutions whose employees or agents
    obtain for research purposes identifiable private
    information or identifiable biological specimens
    from any source for the research.
  • It is important to note that, in general,
    institutions whose employees or agents obtain
    identifiable private information or identifiable
    specimens for non-exempt human subjects research
    are considered engaged in the research, even if
    the institutions employees or agents do not
    directly interact or intervene with human
    subjects.

15
Examples of Engagement OHRP Guidance October 2008
  • In general, obtaining identifiable private
    information or identifiable specimens includes,
    but is not limited to
  • (a) observing or recording private behavior
  • (b) using, studying, or analyzing for research
    purposes identifiable private information or
    identifiable specimens provided by another
    institution and
  • (c) using, studying, or analyzing for research
    purposes identifiable private information or
    identifiable specimens already in the possession
    of the investigators.
  • In general, OHRP considers private information
    or specimens to be individually identifiable as
    defined in 45 CFR 46.102(f) when they can be
    linked to specific individuals by the
    investigator(s) either directly or indirectly
    through coding systems. See scenarios B.(1),
    B.(2), B.(3), B.(7), B.(8), B.(9), and B.(10)
    below for limited exceptions.

16
Examples of Non-Engagement OHRP Guidance October
2008
  • B.(1) Institutions whose employees or agents
    perform commercial or other services for
    investigators provided that all of the following
    conditions also are met
  • (a) the services performed do not merit
    professional recognition or publication
    privileges
  • (b) the services performed are typically
    performed by those institutions for non-research
    purposes and
  • (c) the institutions employees or agents do not
    administer any study intervention being tested or
    evaluated under the protocol.

Question Do personnel that read PET scans for a
study need training?
17
Examples of Non-Engagement OHRP Guidance October
2008
  • B.(2) Institutions not selected as a research
    site whose employees or agents provide clinical
    trial-related medical services that are dictated
    by the protocol and would typically be performed
    as part of routine clinical monitoring and/or
    follow-up of subjects enrolled at a study site by
    clinical trial investigators (e.g., medical
    history, physical examination, assessment of
    adverse events, blood test, chest X-ray, or CT
    scan) provided that all of the following
    conditions also are met
  • (a) the institutions employees or agents do not
    administer the study interventions being tested
    or evaluated under the protocol
  • (b) the clinical trial-related medical services
    are typically provided by the institution for
    clinical purposes
  • (c) the institutions employees or agents do not
    enroll subjects or obtain the informed consent of
    any subject for participation in the research
    and
  • (d) when appropriate, investigators from an
    institution engaged in the research retain
    responsibility for (i) overseeing
    protocol-related activities and (ii) ensuring
    appropriate arrangements are made for reporting
    protocol-related data to investigators at an
    engaged institution, including the reporting of
    safety monitoring data and adverse events as
    required under the IRB-approved protocol.

18
Examples of Non-Engagement OHRP Guidance October
2008
  • B.(3) Institutions not initially selected as a
    research site whose employees or agents
    administer the study interventions being tested
    or evaluated under the protocol limited to a
    one-time or short-term basis provided that all of
    the following conditions also are met
  • (a) an investigator from an institution engaged
    in the research determines that it would be in
    the subjects best interest to receive the study
    interventions being tested or evaluated under the
    protocol
  • (b) the institutions employees or agents do not
    enroll subjects or obtain the informed consent of
    any subject for participation in the research
  • (c) investigators from the institution engaged in
    the research retain responsibility for (i)
    overseeing protocol-related activities (ii)
    ensuring the study interventions are administered
    in accordance with the IRB-approved protocol and
    (iii) ensuring appropriate arrangements are made
    for reporting protocol-related data to
    investigators at the engaged institution,
    including the reporting of safety monitoring data
    and adverse events as required under the
    IRB-approved protocol and
  • (d) an IRB designated on the engaged
    institutions FWA is informed that study
    interventions being tested or evaluated under the
    protocol have been administered at an institution
    not selected as a research site.

19
Examples of Non-Engagement OHRP Guidance October
2008
  • B.(4) Institutions whose employees or agents
  • (a) inform prospective subjects about the
    availability of the research
  • (b) provide prospective subjects with information
    about the research (which may include a copy of
    the relevant informed consent document and other
    IRB approved materials) but do not obtain
    subjects consent for the research or act as
    representatives of the investigators
  • (c) provide prospective subjects with information
    about contacting investigators for information or
    enrollment and/or
  • (d) seek or obtain the prospective subjects
    permission for investigators to contact them.

Question Does your IRB have to approve a study
from another institution that wants to post an
information flyer in your hospital?
20
Examples of Non-Engagement OHRP Guidance October
2008
  • B.(5) Institutions (e.g., schools, nursing homes,
    businesses) that permit use of their facilities
    for intervention or interaction with subjects by
    investigators from another institution.

Question Do you need a local PI and IRB approval
of a study being conducted by VA personnel from
another facility at your hospital if the subjects
are your employees?
21
Examples of Non-Engagement OHRP Guidance October
2008
  • B.(6) Institutions whose employees or agents
    release to investigators at another institution
    identifiable private information or identifiable
    biological specimens pertaining to the subjects
    of the research. Note that in some cases the
    institution releasing identifiable private
    information or identifiable biological specimens
    may have institutional requirements that would
    need to be satisfied before the information or
    specimens may be released, and/or may need to
    comply with other applicable regulations or laws.
    In addition, if the identifiable private
    information or identifiable biological specimens
    to be released were collected for another
    research study covered by 45 CFR part 46, then
    the institution releasing such information or
    specimens should
  • (a) ensure that the release would not violate the
    informed consent provided by the subjects to whom
    the information or biological specimens pertain
    (under 45 CFR 46.116), or
  • (b) if informed consent was waived by the IRB,
    ensure that the release would be consistent with
    the IRBs determinations that permitted a waiver
    of informed consent under 45 CFR 46.116 (c) or
    (d).

Question What is the difference between
release and obtain?
22
Examples of Non-Engagement OHRP Guidance October
2008
  • B.(7) Institutions whose employees or agents
  • (a) obtain coded private information or human
    biological specimens from another institution
    involved in the research that retains a link to
    individually identifying information (such as
    name or social security number) and
  • (b) are unable to readily ascertain the identity
    of the subjects to whom the coded information or
    specimens pertain because, for example
  • the institutions employees or agents and the
    holder of the key enter into an agreement
    prohibiting the release of the key to the those
    employees or agents under any circumstances
  • the releasing institution has IRB-approved
    written policies and operating procedures
    applicable to the research project that prohibit
    the release of the key to the institutions
    employees or agents under any circumstances or
  • there are other legal requirements prohibiting
    the release of the key to the institutions
    employees or agents.

Question Does this infer that it is not research?
23
Examples of Non-Engagement OHRP Guidance October
2008
  • B.(8) Institutions whose employees or agents
    access or utilize individually identifiable
    private information only while visiting an
    institution that is engaged in the research,
    provided their research activities are overseen
    by the IRB of the institution that is engaged in
    the research.
  • B.(9) Institutions whose employees or agents
    access or review identifiable private information
    for purposes of study auditing (e.g. a government
    agency or private company will have access to
    individually identifiable study data for auditing
    purposes).

24
Examples of Non-Engagement OHRP Guidance October
2008
  • B.(10) Institutions whose employees or agents
    receive identifiable private information for
    purposes of satisfying U.S. Food and Drug
    Administration reporting requirements.
  • B.(11) Institutions whose employees or agents
    author a paper, journal article, or presentation
    describing a human subjects research study.

Question Can I help write a paper without having
my IRB review the study?
25
Cooperative research
  • When an institution is engaged in only part of a
    cooperative research project along the lines of
    scenarios A.(2), A.(3), A.(4), A.(5), or A.(6),
    the institution must ensure that the IRB(s)
    designated under its FWA reviews and approves the
    part(s) of the research in which the institution
    is engaged.

26
So, who determines engagement?
  • The PI?
  • The sponsor?
  • The IRB?
  • VHACO?

27
Example Who is engaged?
  • On behalf of the national evaluation team for the
    VA Nursing Academy, we plan to begin contacting
    program leadership from the VA Nursing Academy at
    your VA facility pursuant to approval by the IRB
    and RD committees at the VA Greater Los Angeles
    Healthcare System (VA GLAHS). As you know, VA has
    established a VA Nursing Academy that is
    committed to nursing education and practice and
    will address nursing shortages in VA and across
    the nation by (1) expanding teaching faculty in
    VA facilities and affiliated nursing schools and
    (2) increasing VA recruitment and retention
    through enhanced clinical experiences for nursing
    students and expanded teaching opportunities for
    VA nurses. The national evaluation team is
    conducting the cross-site evaluation on behalf
    of the Office of Academic Affiliations and Office
    of Nursing Services of the Department of Veterans
    Affairs.
  • During the VA Nursing Academy pilot program, we
    plan to interview key (i.e. knowledgeable)
    informants at various organizational levels at
    your facility. We will also conduct surveys of
    faculty and students from the VA Nursing Academy,
    and surveys of other VA nursing personnel who are
    not directly involved in the VA Nursing Academy.
  • Our initial interviews will involve the VA
    Nursing Academy Program Directors of the VA
    facility and the affiliated college/school of
    nursing, the Nurse Executive at your VA facility,
    and the Dean of the college/school of nursing.
    Affiliated faculty of the VA Nursing Academy will
    be interviewed at this time if their schedules
    concur with the established interview schedule.
    Some interviews will be conducted in-person, and
    others will be conducted via telephone.

28
AAHRPP and multisite studies
  • II.8.B The research review unit has and follows
    policies and procedures for management of
    information obtained in multi-site research that
    may be relevant to the protection of research
    participants, such as reporting of unexpected
    problems or interim results

29
Required written materials
  • When the investigator is the lead investigator of
    a multi-site study, policies and procedures have
    applications include information about the
    management of information that is relevant to the
    protection of participants, such as
  • Unanticipated problems involving risks
  • Interim results
  • Protocol modifications

30
Example 2 Who is engaged?
  • CSP study Large multi-site placebo-controlled
    trial in veterans with war zone trauma-induced
    PTSD that prazosin is efficacious for PTSD trauma
    nightmares, sleep disturbance, and global
    clinical status.
  • Study chair site, participating sites,
    coordinating centers (statistics pharmacy
    center)?

31
Which is the lead institution?
  • What are the responsibilities of the IRB at the
    lead institution?

32
QUESTIONS
Write a Comment
User Comments (0)
About PowerShow.com